An Act to amend the Patent Act (patented medicines)

This bill was last introduced in the 37th Parliament, 3rd Session, which ended in May 2004.

This bill was previously introduced in the 37th Parliament, 2nd Session.


Dan McTeague  Liberal

Introduced as a private member’s bill. (These don’t often become law.)


Not active, as of Oct. 24, 2002
(This bill did not become law.)


All sorts of information on this bill is available at LEGISinfo, provided by the Library of Parliament. You can also read the full text of the bill.

Patent ActRoutine Proceedings

October 24th, 2002 / 10:25 a.m.
See context


Dan McTeague Liberal Pickering—Ajax—Uxbridge, ON

moved for leave to introduce Bill C-251, an act to amend the Patent Act (patented medicines)

Mr. Speaker, the bill concerns patented medicines and seeks to amend the Patent Act by repealing the power of the governor in council to make regulations preventing the infringement of the patent by any person who makes, uses, constructs or sells the patent invention solely for uses reasonably related to the development of a submission.

For the information of members, the bill addresses, for example, the inequality of regulations currently attached to the Patent Act. This concerns the rather odious practice of permitting automatic injunctions to some brand name pharmaceutical companies that are claiming patent infringement when in reality they are merely seeking a delay of entry on the market of cheaper generic drugs once an existing patent has expired.

(Motions deemed adopted, bill read the first time and printed)